Efficacy of convalescent plasma therapy in the patient with COVID-19: a randomised control trial (COPLA-II trial)Meenu Bajpai, Ashish Maheshwari, Vikas Dogra, Suresh Kumar, Ekta Gupta, Pratibha kale, Vandana Saluja, Sherin S Thomas, Nirupama Trehanpati, Chhagan Bihari, Reshu Agarwal, Praveen Bharti, Prabha Shankar, Javid Hussain, Karan ChhabraSee the full list of authors
6 April 2022
Treatment decision making (TDM): a qualitative study exploring the perspectives of patients with chronic haematological cancersDorothy McCaughan, Eve Roman, Alexandra Smith, Russell Patmore, Debra Howell
29 March 2022
Improving safety of unfractionated heparin: a retrospective, quasi-experimental, observational study of the impact of a pocket card and a computerised prescription aid tool in the University Hospitals of GenevaWedali E Jimaja, Jerome Stirnemann, Pierre Fontana, Katherine S Blondon
15 March 2022
AKATSUKI study: a prospective, multicentre, phase IV study evaluating the safety of emicizumab under and immediately after immune tolerance induction therapy in persons with congenital haemophilia A with factor VIII inhibitorsTadashi Matsushita, Nobuaki Suzuki, Azusa Nagao, Chiai Nagae, Haruko Yamaguchi-Suita, Yui Kyogoku, Akiko Ioka, Keiji Nogami
14 March 2022
Ferritin-guided iron supplementation in whole blood donors: optimal dosage, donor response, return and efficacy (FORTE)—a randomised controlled trial protocolJan Karregat, Maike G Sweegers, Franke A Quee, Henriëtte H Weekamp, Dorine W Swinkels, Vĕra M J Novotny, Hans L Zaaijer, Katja van den Hurk
9 March 2022
Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trialTobias Menne, Daniel Slade, Joshua Savage, Sarah Johnson, Julie Irving, Pamela Kearns, Ruth Plummer, Geoff Shenton, Gareth J Veal, Britta Vormoor, Josef Vormoor, Lucinda Billingham
4 March 2022
Contribution of the elevated thrombosis risk of males to the excess male mortality observed in COVID-19: an observational studyKenneth Roy Cohen, David Anderson, Sheng Ren, David J Cook
25 February 2022
Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trialKenichi Ogiwara, Masashi Taki, Takashi Suzuki, Hideyuki Takedani, Tadashi Matsushita, Kagehiro Amano, Masanori Matsumoto, Kenji Nishio, Midori Shima, Masato Kasahara, Keiji Nogami
17 February 2022
Status of hospital-based blood transfusion services in low-income and middle-income countries: a cross-sectional international surveyLinda S Barnes, Jean Stanley, Evan M Bloch, Monica B Pagano, Tina S Ipe, Quentin Eichbaum, Silvano Wendel, Alexander Indrikovs, Wei Cai, Meghan Delaney,
15 February 2022
Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN studyJessica M Heijdra, Wala Al Arashi, Nico C B de Jager, Michael E Cloesmeijer, Laura H Bukkems, Christian M Zwaan, Frank W G Leebeek, Ron A A Mathôt, Marjon H Cnossen, , The OPTI-CLOT Study Group, MH Cnossen, FWG Leebeek, K Fijnvandraat, RAA MathôtSee the full list of authors
15 February 2022
